XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous c...
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary
About this item
Full title
Author / Creator
Tamura, Ryo , Yoshihara, Kosuke , Nakaoka, Hirofumi , Yachida, Nozomi , Yamaguchi, Manako , Suda, Kazuaki , Ishiguro, Tatsuya , Nishino, Koji , Ichikawa, Hiroshi , Homma, Keiichi , Kikuchi, Akira , Ueda, Yutaka , Takei, Yuji , Fujiwara, Hiroyuki , Motoyama, Teiichi , Okuda, Shujiro , Wakai, Toshifumi , Inoue, Ituro and Enomoto, Takayuki
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Molecular characteristics of carcinoma arising from mature cystic teratoma of the ovary (MCT) remain unclear due to its rarity. We analyzed RNA-sequencing data of 2322 pan-cancer [1378 squamous cell carcinomas (SCC), 6 adenosquamous carcinomas (ASC), and 938 adenocarcinomas (AC)] including six carcinomas arising from MCT (four SCCs, one ASC, and on...
Alternative Titles
Full title
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary
Authors, Artists and Contributors
Author / Creator
Yoshihara, Kosuke
Nakaoka, Hirofumi
Yachida, Nozomi
Yamaguchi, Manako
Suda, Kazuaki
Ishiguro, Tatsuya
Nishino, Koji
Ichikawa, Hiroshi
Homma, Keiichi
Kikuchi, Akira
Ueda, Yutaka
Takei, Yuji
Fujiwara, Hiroyuki
Motoyama, Teiichi
Okuda, Shujiro
Wakai, Toshifumi
Inoue, Ituro
Enomoto, Takayuki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7176584
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7176584
Other Identifiers
ISSN
0950-9232
E-ISSN
1476-5594
DOI
10.1038/s41388-020-1237-0
